Green Thumb Industries Eyes $297.6M Q1 Revenue as Schedule III Shift Offers Tax Relief
Green Thumb Industries is set to report Q1 results with analysts forecasting $0.02 EPS on $297.64 million revenue and a P/E of 16.39, P/S of 1.62. Federal rescheduling of medical marijuana to Schedule III could unlock a billion-dollar tax benefit for multi-state operators.
1. Q1 2026 Earnings Forecast
Green Thumb Industries will release its first-quarter report on May 6, with consensus estimates calling for $0.02 earnings per share and $297.64 million in revenue, reflecting steady top-line growth expectations for the multi-state operator.
2. Federal Rescheduling Benefit
The U.S. government’s decision to move medical marijuana from Schedule I to Schedule III allows cannabis operators to deduct more business expenses, potentially creating up to a billion dollars in tax savings across the industry, favoring well-capitalized MSOs.
3. Strong Financial Metrics
Green Thumb Industries enters the quarter with a trailing price-to-earnings ratio of 16.39, a price-to-sales ratio of 1.62, a debt-to-equity ratio of 0.27 and a current ratio of 1.55, underscoring healthy valuation and liquidity positions.